Literature DB >> 15164255

Radiological assessment of hydrocephalus: new theories and implications for therapy.

Dan Greitz1.   

Abstract

It is almost a century since Dandy made the first experimental studies on hydrocephalus, but its underlying mechanism has been unknown up to now. The conventional view is that cerebrospinal fluid (CSF) malabsorption due to hindrance of the CSF circulation causes either obstructive or communicating hydrocephalus. Analyses of the intracranial hydrodynamics related to the pulse pressure show that this is an over-simplification. The new hydrodynamic concept presented here divides hydrocephalus into two main groups, acute hydrocephalus and chronic hydrocephalus. It is still accepted that acute hydrocephalus is caused by an intraventricular CSF obstruction, in accordance with the conventional view. Chronic hydrocephalus consists of two subtypes, communicating hydrocephalus and chronic obstructive hydrocephalus. The associated malabsorption of CSF is not involved as a causative factor in chronic hydrocephalus. Instead, it is suggested that increased pulse pressure in the brain capillaries maintains the ventricular enlargement in chronic hydrocephalus. Chronic hydrocephalus is due to decreased intracranial compliance, causing restricted arterial pulsations and increased capillary pulsations. The terms "restricted arterial pulsation hydrocephalus" or "increased capillary pulsation hydrocephalus" can be used to stress the hydrodynamic origin of both types of chronic hydrocephalus. The new hydrodynamic theories explain why third ventriculostomy may cure patients with communicating hydrocephalus, a treatment incompatible with the conventional view.

Entities:  

Mesh:

Year:  2004        PMID: 15164255     DOI: 10.1007/s10143-004-0326-9

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  74 in total

1.  Adult patients with "asymptomatic" and "compensated" hydrocephalus benefit from surgery.

Authors:  A Larsson; H Stephensen; C Wikkelsø
Journal:  Acta Neurol Scand       Date:  1999-02       Impact factor: 3.209

2.  Encephalography in the diagnosis of convexity block hydrocephalus.

Authors:  T Greitz; A Grepe
Journal:  Acta Radiol Diagn (Stockh)       Date:  1971-05

Review 3.  Three decades of normal pressure hydrocephalus: are we wiser now?

Authors:  J A Vanneste
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-09       Impact factor: 10.154

4.  Failed endoscopic third ventriculostomy in children: management options.

Authors:  Aaron Mohanty; M K Vasudev; S Sampath; S Radhesh; V R Sastry Kolluri
Journal:  Pediatr Neurosurg       Date:  2002-12       Impact factor: 1.162

Review 5.  Alternatives to shunting.

Authors:  G Cinalli
Journal:  Childs Nerv Syst       Date:  1999-11       Impact factor: 1.475

6.  Progressive ventricular enlargement in the absence of high ventricular pressure in an experimental neonatal rat model.

Authors:  T Erhan Cosan; Alp I Guner; Nevbahar Akcar; Kubilay Uzuner; Esref Tel
Journal:  Childs Nerv Syst       Date:  2002-01-23       Impact factor: 1.475

7.  Pulse-wave encephalopathy: a comparative study of the hydrodynamics of leukoaraiosis and normal-pressure hydrocephalus.

Authors:  G A Bateman
Journal:  Neuroradiology       Date:  2002-06-20       Impact factor: 2.804

8.  Association of deep white matter infarction with chronic communicating hydrocephalus: implications regarding the possible origin of normal-pressure hydrocephalus.

Authors:  W G Bradley; A R Whittemore; A S Watanabe; S J Davis; L M Teresi; M Homyak
Journal:  AJNR Am J Neuroradiol       Date:  1991 Jan-Feb       Impact factor: 3.825

9.  Complications of endoscopic third ventriculostomy.

Authors:  Henry W S Schroeder; Wulf-Rüdiger Niendorf; Michael R Gaab
Journal:  J Neurosurg       Date:  2002-06       Impact factor: 5.115

10.  Brain elasticity changes with ventriculomegaly.

Authors:  F H Sklar; J T Diehl; C W Beyer; W K Clark
Journal:  J Neurosurg       Date:  1980-08       Impact factor: 5.115

View more
  89 in total

1.  The hydrodynamic hypothesis versus the bulk flow hypothesis.

Authors:  Dan Greitz
Journal:  Neurosurg Rev       Date:  2004-07-23       Impact factor: 3.042

2.  Neocortical capillary flow pulsatility is not elevated in experimental communicating hydrocephalus.

Authors:  Shams Rashid; James P McAllister; Yiting Yu; Mark E Wagshul
Journal:  J Cereb Blood Flow Metab       Date:  2011-09-21       Impact factor: 6.200

3.  Assessment of craniospinal pressure-volume indices.

Authors:  A Wåhlin; K Ambarki; R Birgander; N Alperin; J Malm; A Eklund
Journal:  AJNR Am J Neuroradiol       Date:  2010-07-01       Impact factor: 3.825

4.  Proton MR spectroscopy and white matter hyperintensities in idiopathic normal pressure hydrocephalus and other dementias.

Authors:  O Algin; B Hakyemez; M Parlak
Journal:  Br J Radiol       Date:  2010-07-20       Impact factor: 3.039

5.  Reply: To PMID 25977480.

Authors:  G Ringstad; K E Emblem; O Geier; N Alperin; P K Eide
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-06       Impact factor: 3.825

Review 6.  The differential diagnosis and treatment of normal-pressure hydrocephalus.

Authors:  Michael Kiefer; Andreas Unterberg
Journal:  Dtsch Arztebl Int       Date:  2012-01-09       Impact factor: 5.594

Review 7.  Unraveling the riddle of syringomyelia.

Authors:  Dan Greitz
Journal:  Neurosurg Rev       Date:  2006-05-31       Impact factor: 3.042

8.  Extending the hydrodynamic hypothesis in chronic hydrocephalus.

Authors:  Grant A Bateman
Journal:  Neurosurg Rev       Date:  2005-07-12       Impact factor: 3.042

9.  [Idiopathic normal-pressure hydrocephalus. Flow measurement of cerebrospinal fluid using phase contrast MRI and its diagnostics importance].

Authors:  F T Al-Zain; G Rademacher; J Lemcke; J Mutze; U Meier
Journal:  Nervenarzt       Date:  2007-02       Impact factor: 1.214

10.  Hydrocephalus after intraventricular hemorrhage: the role of thrombin.

Authors:  Feng Gao; Fuyi Liu; Zhi Chen; Ya Hua; Richard F Keep; Guohua Xi
Journal:  J Cereb Blood Flow Metab       Date:  2013-12-11       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.